Fda Bla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FDA has accepted a biologics license application for subcutaneous nivolumab for adult patients eligible for approved solid tumor nivolumab indications.

United statesGina fusaroDrug administrationBristol myers squibbEuropean unionPrescription drug user fee actBlinded independent centralBristol myersSubcutaneous nivolumabSubcutaneous nivolumab in advanced or metastatic solid tumorsFda blaCheckmate 67t study nct04810078